The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...

In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...

The newly installed Trump administration late Tuesday prompted federal health agencies, including the Centers for Medicare & Medicaid Services (CMS), ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...

Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

The Biden administration’s last MA rule is a boon for insurers, though it remains to be seen how the incoming Trump ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...